Tech Company Financing Transactions

BlossomHill Therapeutics Funding Round

On 12/10/2025, BlossomHill Therapeutics raised $84 million in Series B funding from BioTrack Capital, Brahma Capital and Janus Henderson Investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10255 Science Center Drive 200
San Diego, CA 92121
USA

Phone

(858) 732-3880

Website

www.bhtherapeutics.com

Email Address

[email protected]

Overview

At BlossomHill, we are on a mission to redefine precision medicine and make a leap forward in life expectancy and quality of life for patients. Our cancer therapies are exquisitely designed to be potent against cancer drivers and aim to address cancer's resistance to treatment from multiple angles. Our autoimmune programs seek to tackle difficult challenges to deliver life-changing therapies for patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Y. Peter Li

        

Chief Executive Officer

J. Jean Cui

        

Chief Financial Officer

Jason Keyes

        

Chief Medical Officer

Geoff Oxnard

        

Vice President

Antonio Garrido-Montalban

        

Vice President

Eugene Rui

        

Vice President

Z. Jesse Shao

        

Vice President

Jill Smith

        

Vice President

Diane Wang

        

Vice President

Zachary Zimmerman

        

VP - General Counsel

Vincent Liptak

        

VP - Regulatory Affairs

Ashley Preston

        

Browse more venture capital transactions:

Prev: 12/10/2025: Nu Quantum venture capital transaction
Next: 12/10/2025: Kilo Code venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary